Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis

Xueting Li; Alexander C. Rokohl; Xiaojun Ju; Yongwei Guo; Xincen Hou; Wanlin Fan; Ludwig M. Heindl

doi:10.1016/j.aopr.2024.08.001

您当前的位置：

首页 >

文章列表页 >

Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis

Full Length Article | 更新时间：2024-12-14

- Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis
- Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis
- 眼科实践与研究新进展 2024年4卷第4期页码：209-215
- 作者机构：
  
  1. Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne,Cologne,Germany
  2. Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf,Cologne,Germany
  3. Eye Center, the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2024.08.001
  中图分类号：
- 纸质出版日期：2024，
- 稿件说明：
移动端阅览
Xueting Li, Alexander C. Rokohl, Xiaojun Ju, 等. Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis[J]. 眼科实践与研究新进展, 2024,4(4):209-215.

XUETING LI, ALEXANDER C. ROKOHL, XIAOJUN JU, et al. Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis. [J]. Aopr, 2024, 4(4): 209-215.
Xueting Li, Alexander C. Rokohl, Xiaojun Ju, 等. Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis[J]. 眼科实践与研究新进展, 2024,4(4):209-215. DOI： 10.1016/j.aopr.2024.08.001.

XUETING LI, ALEXANDER C. ROKOHL, XIAOJUN JU, et al. Global research trends in the treatment of squamous cell carcinoma over the past decade: A bibliometric analysis. [J]. Aopr, 2024, 4(4): 209-215. DOI： 10.1016/j.aopr.2024.08.001.

摘要

Abstract

ObjectiveThis study aims to identify research trends and hot spots in the treatment of Squamous Cell Carcinoma (SCC) over the past decade using bibliometric analysis.MethodsData were extracted from the Web of Science Core Collection

including Science Citation Index Expanded (SCI-Expanded)

Social Sciences Citation Index (SSCI)

and Emerging Sources Citation Index (ESCI). The data underwent manual cleaning to remove inaccuracies and irrelevancies

followed by transformation into an analyzable format via the VOSviewer software. This tool facilitated the visualization of co-occurrence networks and keyword maps

highlighting the relationships and the prominence of research themes.ResultsA total of 46448 authors from 7374 institutions across 108 countries contributed to the literature

reflecting a broad international effort. The study documented a consistent increase in SCC-related publications up to 2020

with some variability in subsequent years. Notably

the United States

Germany

China

the United Kingdom

and France were predominant in this research area. The University of Texas MD Anderson Cancer Center and the University of Pittsburgh were leading contributors in terms of publication volume and citation impact. Key journals included ‘Oral Oncology’ and ‘Clinical Cancer Research’

which were central to the dissemination of high-impact research. Our keyword analysis identified three major research clusters focused on molecular mechanisms

clinical treatment strategies

and emerging interests in immunotherapeutic approaches.ConclusionsThe extensive collaboration and the increasing publication trend underscore the growing global commitment to advancing SCC treatment. The high level of engagement from top institutions and the concentration of research in influential journals reflect the field's dynamic evolution towards innovative and effective treatment modalities. This study provides a valuable overview for researchers

guiding future studies towards areas of high impact and emerging trends in SCC treatment. The findings advocate for enhanced focus on personalized medicine and combination therapies

which are poised to improve outcomes for SCC patients.

关键词

Keywords

Squamous cell carcinomaBibliometric analysisTreatment

references

1 I. Asproudis, et al.Eyelid tumors at the university eye clinic of ioannina, Greece: a 30-year retrospective study Middle East Afr J Ophthalmol, 22 (2015), pp. 230-232, 10.4103/0974-9233.151881

2 A. Galindo-Ferreiro, et al.Primary periocular squamous cell carcinoma in central Spain: factors related to recurrence Eur J Ophthalmol, 32 (2022), pp. 2101-2107, 10.1177/11206721211035629

3 V.T. Yin, H.A. Merritt, M. Sniegowski, B. EsmaeliEyelid and ocular surface carcinoma: diagnosis and management Clin Dermatol, 33 (2015), pp. 159-169, 10.1016/j.clindermatol.2014.10.008

4 L. Hogue, V.M. HarveyBasal cell carcinoma, squamous cell carcinoma, and cutaneous melanoma in skin of color patients Dermatol Clin, 37 (2019), pp. 519-526, 10.1016/j.det.2019.05.009

5 R.M. Halder, K.M. BangSkin cancer in blacks in the United States Dermatol Clin, 6 (1988), pp. 397-405

6 B.E. Cook Jr., G.B. BartleyEpidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota Ophthalmology, 106 (1999), pp. 746-750, 10.1016/s0161-6420(99)90161-6

7 X. Ju, et al.Therapy failure and resistance mechanism in eyelid and ocular surface tumors Neurosignals, 30 (2022), pp. 21-38, 10.33594/000000560

8 M.R. Karagas, et al.Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin J Natl Cancer Inst, 98 (2006), pp. 389-395, 10.1093/jnci/djj092

9 E.N. Pritchett, et al.Nonmelanoma skin cancer in nonwhite organ transplant recipients JAMA Dermatol, 152 (2016), pp. 1348-1353, 10.1001/jamadermatol.2016.3328

10 A. Badakere, P. Patil-ChhablaniOrbital apex syndrome: a review Eye Brain, 11 (2019), pp. 63-72, 10.2147/eb.S180190

11 A. Ninkov, J.R. Frank, L.A. MaggioBibliometrics: methods for studying academic publishing Perspect Med Educ, 11 (2022), pp. 173-176, 10.1007/s40037-021-00695-4

12 E. Danopoulos, L.C. Jenner, M. Twiddy, J.M. RotchellMicroplastic contamination of seafood intended for human consumption: a systematic review and meta-analysis Environ Health Perspect, 128 (2020), Article 126002, 10.1289/ehp7171

13 M. Mishra, et al.An overview of research on natural resources and indigenous communities: a bibliometric analysis based on Scopus database (1979-2020) Environ Monit Assess, 193 (2021), p. 59, 10.1007/s10661-020-08793-2

14 M. Mishra, et al.A bibliometric analysis of sustainable development goals (SDGs): a review of progress, challenges, and opportunities Environ Dev Sustain, 1–43 (2023), 10.1007/s10668-023-03225-w

15 S. Li, et al.Mapping research trends of uveal melanoma: a bibliometric analysis Int Ophthalmol, 42 (2022), pp. 1121-1131, 10.1007/s10792-021-02098-0

16 J. Yin, et al.TP53 common variants and interaction with PPP1R13L and CD3EAP SNPs and lung cancer risk and smoking behavior in a Chinese population Biomed J, 45 (2022), pp. 169-178, 10.1016/j.bj.2021.01.006

17 T. Fukusumi, J.A. CalifanoThe NOTCH pathway in head and neck squamous cell carcinoma J Dent Res, 97 (2018), pp. 645-653, 10.1177/0022034518760297

18 M. Zhang, et al.Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? Cancer Med, 5 (2016), pp. 2048-2060, 10.1002/cam4.731

19 M. Dillon, et al.Progress on Ras/MAPK signaling research and targeting in blood and solid cancers Cancers (Basel), 13 (2021), 10.3390/cancers13205059

20 Y. Luo, et al.Novel MSH6 mutation predicted metastasis in eyelid and periocular squamous cell carcinoma J Eur Acad Dermatol Venereol, 36 (2022), pp. 2331-2342, 10.1111/jdv.18454

21 N. Di Girolamo, A. Atik, P.J. McCluskey, D. WakefieldMatrix metalloproteinases and their inhibitors in squamous cell carcinoma of the conjunctiva Ocul Surf, 11 (2013), pp. 193-205, 10.1016/j.jtos.2013.01.006

22 C.B. van Lee, et al.Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study Br J Dermatol, 181 (2019), pp. 338-343, 10.1111/bjd.17188

23 D.D. Xiong, et al.Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision J Am Acad Dermatol, 82 (2020), pp. 1195-1204, 10.1016/j.jaad.2019.12.049

24 G. Marrazzo, J.A. Zitelli, D. BrodlandClinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone J Am Acad Dermatol, 80 (2019), pp. 633-638, 10.1016/j.jaad.2018.09.015

25 M. Badwelan, H. Muaddi, A. Ahmed, K.T. Lee, S.D. TranOral squamous cell carcinoma and concomitant primary tumors, what do we know? A review of the literature Curr Oncol, 30 (2023), pp. 3721-3734, 10.3390/curroncol30040283

26 M. Garg, J.J. BeitlerControversies in management of the neck in head and neck cancer Curr Treat Options Oncol, 5 (2004), pp. 35-40, 10.1007/s11864-004-0004-8

27 H.K. Kao, et al.Multiple concomitant oral cavity cancers: incidence, management, and outcomes J Surg Oncol, 115 (2017), pp. 835-841, 10.1002/jso.24600

28 D.G. Brodland, J.A. ZitelliSurgical margins for excision of primary cutaneous squamous cell carcinoma J Am Acad Dermatol, 27 (1992), pp. 241-248, 10.1016/0190-9622(92)70178-i

29 NCCN clinical Practice guidelines in Oncology: squamous cell skin cancer https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf (2019)

30 A.J. Stratigos, et al.European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention Eur J Cancer, 128 (2020), pp. 60-82, 10.1016/j.ejca.2020.01.007

31 S.G. Keohane, et al.British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020 Br J Dermatol, 184 (2021), pp. 401-414, 10.1111/bjd.19621

32 P. Niinimäki, M. Siuko, O. Tynninen, T.T. Kivelä, M. UusitaloCutaneous squamous cell carcinoma of the eyelid in northern latitudes, a 25-year experience in Finland Acta Ophthalmol (2023), 10.1111/aos.15819

33 K.A. Burton, K.A. Ashack, A. KhachemouneCutaneous squamous cell carcinoma: a review of high-risk and metastatic disease Am J Clin Dermatol, 17 (2016), pp. 491-508, 10.1007/s40257-016-0207-3

34 B. O'DonnellSquamous cell carcinoma of the eyelids and periorbital areas Clin Exp Ophthalmol, 35 (2007), pp. 111-112, 10.1111/j.1442-9071.2007.01474.x

35 J. Hind, et al.Outcomes of cataract surgery in patients previously treated with orbital radiotherapy J Cataract Refract Surg, 48 (2022), pp. 162-167, 10.1097/j.jcrs.0000000000000717

36 M. Reigneau, et al.Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas Br J Dermatol, 173 (2015), pp. 527-534, 10.1111/bjd.13741

37 A. Jarkowski 3rd, et al.Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): the roswell park experience and a review of the literature Am J Clin Oncol, 39 (2016), pp. 545-548, 10.1097/coc.0000000000000088

38 C.H. Adelmann, et al.MEK is a therapeutic and chemopreventative target in squamous cell carcinoma J Invest Dermatol, 136 (2016), pp. 1920-1924, 10.1016/j.jid.2016.05.110

39 E. Larkins, et al.FDA approval summary: pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy Oncol, 22 (2017), pp. 873-878, 10.1634/theoncologist.2016-0496

40 E.E.W. Cohen, et al.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) J Immunother Cancer, 7 (2019), p. 184, 10.1186/s40425-019-0662-5

41 S. Farkona, E.P. Diamandis, I.M. BlasutigCancer immunotherapy: the beginning of the end of cancer? BMC Med, 14 (2016), p. 73, 10.1186/s12916-016-0623-5

42 M. Hecht, et al.Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 J Immunother Cancer, 8 (2020), 10.1136/jitc-2020-001378

43 X. Li, et al.Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma BMC Cancer, 21 (2021), p. 622, 10.1186/s12885-021-08373-8

44 S. Ju, et al.Personalized treatment concepts in extraocular cancer Adv Ophthalmol Pract Res, 4 (2024), pp. 69-77, 10.1016/j.aopr.2024.02.003

45 L.A. Habib, N. Wolkow, S.K. Freitag, M.K. YoonAdvances in immunotherapy and periocular malignancy Semin Ophthalmol, 34 (2019), pp. 327-333, 10.1080/08820538.2019.1620813

46 D. Wang, et al.Photodynamic therapy of intravenous injection combined with intratumoral administration of photosensitizer in squamous cell carcinoma Photodiagnosis Photodyn Ther, 38 (2022), Article 102857, 10.1016/j.pdpdt.2022.102857

47 Q. Chen, et al.Successful treatment of upper-left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA-PDT/holmium laser combination therapy Photodiagnosis Photodyn Ther, 34 (2021), Article 102277, 10.1016/j.pdpdt.2021.102277

48 R. Zappasodi, T. Merghoub, J.D. WolchokEmerging concepts for immune checkpoint blockade-based combination therapies Cancer Cell, 33 (2018), pp. 581-598, 10.1016/j.ccell.2018.03.005

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Understanding parental hurdles in accessing strabismus treatment

Personalized treatment approaches in intraocular cancer

Global research on artificial intelligence in thyroid-associated ophthalmopathy: A bibliometric analysis